Articles by January, 2024

In a significant development following the Paris summit, NBC reports that Israel has agreed to the mediators' proposal for a hostage deal. The proposal, set to be sent to Hamas today, outlines a plan for the staged release of abductees. The deal is contingent upon a prolonged ceasefire and the delivery of aid shipments to Gaza

In a move reflective of the challenging economic landscape, Osem Nestlé and Unilever have announced price hikes on a range of products starting March 1. Osem Nestlé's price adjustments will affect popular items such as Sabar salads, Tivol products, Bonjour pastries, Osem ketchup, noodles for soup, sauces, cookies, and chocolate-based products like Apropos and Kitkat. The increases vary between 3% and 9%, with some products seeing an 8%-5% rise. Osem Nestlé emphasized that this adjustment pertains to around 14% of its total product offerings, primarily those produced in industrial plants...

Teva Pharmaceutical Industries, a leading pharmaceutical giant, has announced a notable annual revenue growth of 6.2% for 2023, bringing in a total of $15.8 billion. After enduring five consecutive years of decline, this resurgence is attributed to a substantial advance payment of $500 million received from Snoopy Pharmaceuticals as part of a collaborative effort on an innovative anti-TL1A drug

The IMF economists express concerns that the conflict in Gaza could escalate further, and continued attacks by the Houthis in the Red Sea, a crucial route for 11% of world trade, could disrupt supply chains and impede the global recovery. The ongoing war in Ukraine adds to the risks, potentially causing spikes in food, energy, and transportation prices, which have already seen a sharp increase